PsyKey
Inc Announces Letter of Intent with
MycoVita Canada to Form Strategic Partnership for Advanced Mycology
Product Development
Las Vegas, Nevada, April
14, 2021 - CECORS, INC.
(OTC
PINK: CEOS) ("CeCors" or the "Company"), is pleased to announce
that its wholly owned Canadian subsidiary PsyKey Inc. has entered
into a letter of intent with MycoVita Canada Inc. ("MycoVita") to
form a strategic partnership. The PsyKey – MycoVita strategic
partnership will focus on the research, development, and
commercialization of Mycology based formulations, products, and
therapeutics, including exploring scientific and research-based
approaches in regards to psilocybin and its uses as a potential
therapeutic.
MycoVita, whose name is
derived from Latin meaning "mushroom life" is a Biotech company
focused on the development of functional foods and products that
support optimal health and wellbeing through science backed
formulations and research. Mushrooms and their derived bio-products
offer unique benefits for both the body and mind, ranging from
immune support, cognition and memory enhancement, to energy and
stamina boost. MycoVita is targeting these areas to deliver
measurable results for healthy outcomes.
MycoVita was founded by
Dr. Omon Isikhuemhen who is currently a leading mushroom science
and fungal biotechnology professor at the North Carolina A&T
State University. Dr. Isikhuemhen credentials include a Bachelor of
Science with honors, a Masters of Science in Botany, as well
as a Ph.D in
Microbiology. Dr. Isikhuemhen is a trail blazer in research and
development that has resulted in many technological advancements,
products, and numerous scientific publications.
"The synergies of the
PsyKey – MycoVita strategic partnership are truly exciting. Having
the opportunity to partner with a company founded by a world class
mycologist, whose goals and ambitions align with those of ours,
will provide us with significant advantages as we continue to
execute our growth and expansion strategy in the fast-evolving
market for mycology based products and therapeutics," said Amar
Bhatal, president of CeCors Inc. "We look forward to announcing
more about our exciting planned products and additional business
developments in the near future."
For further
information:
Publicly traded company (OTC
Pink: CEOS)
Website: www.psykeyworld.com
E-mail:info@psykeyworld.com
Follow us on Twitter: https://twitter.com/PsyKeyworld
Forward-Looking
Statements:
Safe Harbour Statement
- In addition to historical information, this press release may
contain statements that constitute forward-looking statements
within the meaning of the Securities Act of 1933 and the Securities
Exchange Act of 1934, as amended by the Private Securities
Litigation Reform Act of 1995. Forward-looking statements contained
in this press release include the intent, belief, or expectations
of the Company and members of its management team with respect to
the Company's future business operations and the assumptions upon
which such statements are based. Prospective investors are
cautioned that any such forward-looking statements are not
guarantees of future performance, and involve risks and
uncertainties and that actual results may differ materially from
those contemplated by such forward-looking statements. Factors that
could cause these differences include, but are not limited to,
failure to complete anticipated sales under negotiations, lack of
revenue growth, client discontinuances, failure to realize
improvements in performance, efficiency, and profitability, and
adverse developments with respect to litigation or increased
litigation costs, the operation or performance of the Company's
business units or the market price of its common stock. Additional
factors that could cause actual results to differ materially from
those contemplated within this press release can also be found on
the Company's website. The Company disclaims any responsibility to
update any forward- looking statements.